CAMP and shigellosis: Consistent with their HDP-inducing activity in cells, oral supplementation of sodium butyrate or PBA improved the clinical outcomes of shigellosis in both humans and rabbits by counteracting Shigella-induced downregulation of CAMP expression in the intestinal tract [37,158].